Early-Term Outcomes for Treatment of Saphenous Vein Insufficiency with N-Butyl Cyanoacrylate: A Novel, Non-Thermal, and Non-Tumescent Percutaneous Embolization Technique
DOI:
https://doi.org/10.1532/hsf.1496Abstract
Background: The purpose of this study was to present early-term outcomes of VariClose® Vein Sealing System, which is a novel, non-thermal, and non-tumescent percutaneous embolization technique for treatment of saphenous vein insufficiency.Methods: Between March 2014 and July 2015, 189 saphenous veins in 141 patients were treated with Variclose Vein Sealing System containing n-butyl cyanoacrylate. Pre-, intra-, post-procedural, and follow-up data of patients were collected and retrospectively reviewed.
Results: Mean age of patients was 42.5 ± 14.0 years, of which 53% were female. Technical success rate of intervention was 98.9%. Mean procedure time was 14.3 ± 7.5 minutes. Eighty-nine percent of patients (n = 126/141) were available at mean follow-up time of 6.7 months. Mean Venous Clinical Severity Score was significantly improved from 8.3 ± 2.2 at pre-procedure period to 3.3 ± 1.8 at follow-up. No complete recanalization was observed, but 2 patients were presented with partial recanalization during follow-up. The complete occlusion rate was 98.4%. No serious adverse event related to procedure was observed.
Conclusion: Variclose Vein Sealing System appears to be safe and effective in treatment of saphenous vein insufficiency. Further randomized studies with long-term outcomes are required for determining optimal treatment modality in patients with saphenous vein insufficiency.
References
Akahoshi T, Hashizume M, Shimabukuro R, et al. 2002. Long-term results of endoscopic histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 131(1 Suppl):S176-81.
Almeida JI, Kaufman J, Göckeritz O, et al. 2009. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol 20:752-9.
Almeida JI, Min RJ, Raabe R, McLean DJ, Madsen M. 2011. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovascular Surg 45:631-5.
Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. 2015. Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology 30:397-404.
Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. 2005. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 15:175-84.
Carradice D, Mazari FA, Samuel N, Allgar V, Hatfield J, Chetter IC. 2011. Modelling the effect of venous disease on quality of life. Br J Surg 98:1089-98.
Ceulen RP, Bullens-Goessens YI, Pi-VAN DE Venne SJ, Nelemans PJ, Veraart JC, Sommer A. 2007. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg 33:276-81.
Gillet JL, Guedes JM, Guex JJ, et al. 2009. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology 24:131-8.
Gloviczki P, Comerota AJ, Dalsing MC, et al. 2011. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 53:2S-48S
Kerver AL, van der Ham AC, Theeuwes HP, et al. 2012. The surgical anatomy of the small saphenous vein and adjacent nerves in relation to endovenous thermal ablation. J Vasc Surg 56:181-8.
Labropoulos N, Leon M, Nicolaides AN, Giannoukas AD, Volteas N, Chan P. 1994. Superficial venous insufficiency: correlation of anatomic extent of reflux with clinical symptoms and signs. J Vasc Surg 20:953-8.
Lattimer CR, Kalodiki E, Azzam M, Makris GC, Somiayajulu S, Geroulakos G. 2013. Interim results on abolishing reflux alongside a randomized clinical trial on laser ablation with phlebectomies versus foam sclerotherapy. Int Angiol 32:394-403.
Lawson J, Gauw S, van Vlijmen C, et al. 2013. Sapheon: the solution? Phlebology 28(Suppl 1):2-9.
Malgor RD, Gasparis AP, Labropoulos N. 2015. Morbidity and mortality after thermal venous ablations. Int Angiol 35:57-61.
McHugh SM, Leahy AL. 2014. What next after thermal ablation for varicose veins: non-thermal ablation? Surgeon 12:237-8.
Morrison N, Gibson K, McEnroe S, et al. 2015. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg 61:985-94.
Navarro L, Min RJ, Boné C. 2001. Endovenous laser: a new minimally invasive method of treatment for varicose veins--preliminary observations using an 810 nm diode laser. Dermatol Surg 27:117-22.
Pollak JS, White RI Jr. 2001. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 12:907-13.
Proebstle TM, Alm J, Göckeritz O, et al. 2011. Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg 54:146-52.
Proebstle TM, Alm J, Dimitri S, et al. 2015. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg: Venous and Lym Dis 3:2-7.
Rabe E, Otto J, Schliephake D, Pannier F. 2008. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 35:238-45.
Van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. 2009. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 49:230-9.
Van den Bremer J, Moll FL. 2010. Historical overview of varicose vein surgery. Ann Vasc Surg 24:426-32.
Welch HJ. 2006. Endovenous ablation of the great saphenous vein may avert phlebectomy for branch varicose veins. J Vasc Surg 44:601-5.
